发明名称 |
(+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE, COMPOSITIONS AND USES THEREOF |
摘要 |
<p>The present invention relates to (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable salts thereof compositions comprising (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and methods for treating of or preventing relapse of depression, anxiety disorders, eating disorders, or urinary incontinence in a patient comprising administering (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof. The (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or pharmaceutically acceptable salt therof is preferably substantially free of its corresponding (-)-enantiomer.</p> |
申请公布号 |
WO02066427(A3) |
申请公布日期 |
2003.03.13 |
申请号 |
WO2002US00845 |
申请日期 |
2002.01.11 |
申请人 |
DOV PHARMACEUTICAL, INC.;LIPPA, ARNOLD, STAN;EPSTEIN, JOSEPH, WILLIAM |
发明人 |
LIPPA, ARNOLD, STAN;EPSTEIN, JOSEPH, WILLIAM |
分类号 |
A61K45/00;A61K31/40;A61K31/403;A61K31/407;A61K45/06;A61P1/14;A61P3/04;A61P7/12;A61P13/10;A61P25/00;A61P25/18;A61P25/22;A61P25/24;A61P25/30;A61P25/32;C07D209/52;C07D471/08;(IPC1-7):C07D209/52 |
主分类号 |
A61K45/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|